The move is part of the company's efforts to consolidate the shareholding of various promoters.
As many as 3.84 crore shares were transferred to Athanas Enterprises and Abellon Energy, the two promoters of pharma company.
According to bulk deal data available with the BSE, Claris Lifesciences' four promoters--Aditya S Handa, Arjun Handa, Medical Technologies and Sarjan Financial--transfered a total of 3.84 crore shares, amounting to 60.21 per cent, of the company worth Rs 801 crore.
Besides, Medical Technologies has transfered 46.53 lakh, while Sarjan Financial has shifted 2.37 crore scrips of Claris Lifesciences at a price of Rs 204.7 per share.
Of total 60.2 per cent shares transfered, 49.48 per cent holding has been acquired by Athanas Enterprises and the remaining 10.72 per cent by Abellon Energy.
As of September quarter, the promoters along with Arjun Handa held 60.21 per cent stake or 3.84 crore shares in the company.
Claris Lifesciences shares fell by 2.09 per cent to close at Rs 194.30 apiece on the BSE.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
